Search
Drug Impact Events
| Date | Lead Company |
Event | Type | Approval Change |
Approval Likelihood |
|---|---|---|---|---|---|
| 8/22/17 | Encore Dermatology | DFD-06 Cream for Psoriasis | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/22/17 | Astellas (4503:JP) | Gilteritinib for Acute Myelogenous Leukemia (AML) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/22/17 | Takeda (TKPYY) | Entyvio for Ulcerative Colitis (UC) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/22/17 | Novogen (NVGN) | RG7666 for Brain Cancer (Malignant Glioma; AA and GBM) | Subscribers Only | Subscribers Only | Subscribers Only |
| 8/21/17 | Ironwood (IRWD) | Duzallo for Gout | Subscribers Only | Subscribers Only | Subscribers Only |
Upcoming Catalysts
| Expected Date Range |
Lead Company |
Drug | Expected Catalyst |
|---|---|---|---|
| 08/24/17 | Subscribers Only | Subscribers Only | Regulatory - PDUFA/Approval Decision (US) |
| 08/24/17 | Subscribers Only | Subscribers Only | Company - Analyst/R&D Update |
| 08/25/17 | Subscribers Only | Subscribers Only | Regulatory - PDUFA for sNDA/sBLA |
| 08/25/17 | Subscribers Only | Subscribers Only | Company - Earnings Announcement |
| 08/25/17 | Subscribers Only | Subscribers Only | Trial Data - Other |
Special Reports
26.jpg "Hormone Refractory Prostate Cancer Therapies, Phase III & Pivotal Phase II")
27.jpg "Pancreatic Cancer Therapies, Phase III & Pivotal Phase II")
Latest Pharma Insights
BioMedTracker in the News
| Date | Headline |
|---|---|
| 06/16/17 | Market watch: Upcoming market catalysts in Q3 2017 |
| 03/17/17 | Market watch: Upcoming market catalysts in Q2 2017 |
| 12/29/16 | Market watch: Upcoming market catalysts in Q1 2017 |
| 09/29/16 | Market watch: Upcoming market catalysts in Q4 2016 |
| more... | |